Reference Limits of Apolipoprotein A-I and Apolipoprotein B Using an IFCC Standardized Immunonephelometric Method
- 1 January 1995
- journal article
- Published by Walter de Gruyter GmbH in cclm
- Vol. 33 (6), 337-342
- https://doi.org/10.1515/cclm.1995.33.6.337
Abstract
An important collaborative study organized by the IFCC enabled the selection of international reference materials and the standardization of commercially available methods by the use of common calibrators. In this paper, we report the reference limits of apolipoprotein A-I and apolipoprotein B in a selected healthy French population. The apolipoprotein measurements were performed on BNA Behring using reagents and protocols supplied by the manufacturer: the standard sera were calibrated using the IFCC-WHO reference preparations (SP1 and SP3). In addition, the apolipoprotein B protocol was modified by the addition of a supplementary reagent to reduce the interference by lipaemic samples on immunonephelometric measurement. In a sample of 115 random serum samples, there was a decrease in mean concentration between non-standardized and standardized methods: -4.8% for apolipoprotein A-I and -4.7% for apolipoprotein B. The reference limits for apolipoprotein A-I are unaffected by gender between 4 and 14 years, thereafter vary with age and gender until 40 years and with gender alone between 40 and 60 years. For apolipoprotein B, the variation with gender is only significant between 30 and 49 years.Keywords
This publication has 10 references indexed in Scilit:
- Apolipoproteins A-I and B as predictors of angiographically defined coronary artery diseaseArchives of Internal Medicine, 1990
- Standardization of the Immunochemical Determination of Apolipoproteins A-I and B: A Report on the International Federation of Clinical Chemistry Meeting on Standardization of Apolipoprotein A-I and B Measurements (Basis for Future Consensus), Vienna, Austria, April 18-19, 1989Clinical Chemistry, 1989
- Cigarette smoking and serum lipid and lipoprotein concentrations: an analysis of published data.BMJ, 1989
- Apolipoproteins AI, AII and B in young adults: Associations with CHD risk factors. The Beaver County experienceJournal of Chronic Diseases, 1986
- Effect of alcohol intake and exercise on plasma high-density lipoprotein cholesterol subfractions and apolipoprotein A-I in womenThe American Journal of Cardiology, 1986
- Epidemiological correlates of high density lipoprotein subfractions, apolipoproteins A-I, A-II, and D, and lecithin cholesterol acyltransferase. Effects of smoking, alcohol, and adiposity.Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1985
- Physiologic and supraphysiologic increases in lipoprotein lipids and apoproteins in late pregnancy and postpartum. Possible markers for the diagnosis of "prelipemia".Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1984
- Discriminative value of lipids and apoproteins in coronary heart diseaseAtherosclerosis, 1982
- Plasma HDL Cholesterol and Growth Hormone in Epileptics Treated with AnticonvulsantsActa Pharmacologica et Toxicologica, 1980
- ARE APOLIPOPROTEINS BETTER DISCRIMINATORS THAN LIPIDS FOR ATHEROSCLEROSIS?The Lancet, 1979